Health product recall

Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity)

Last updated

Summary

Product
Mint-Rosuvastatin Tablet
Issue
Health products - Product quality
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot numbers

Mint Pharmaceuticals

Mint-Rosuvastatin 10 mg tablet

DIN 02397803

Tablet

Rosuvastatin calcium 10 mg

14240935B, 14240936B, 14240937A, 14240934A, 14240935A, 14240936A

Mint Pharmaceuticals

Mint-Rosuvastatin 20 mg tablet

DIN 02397811

Tablet

Rosuvastatin calcium 20 mg

14240938A, 14240939A, 14240940A, 14240938B, 14240939B, 14240940B

Mint Pharmaceuticals

Mint-Rosuvastatin 40 mg tablet

DIN 02397838

Tablet

Rosuvastatin calcium 40 mg

14240941A, 14240942A

Issue

The Impurity is out of specification in the affected lots.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Mint Pharmaceuticals Inc

6575 Davand Drive, 

Mississauga, ON L5T 2M3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-77183

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe